WPRIM Management System> DCMS> Chinese Journal of Cancer> 2010> 29> 3

Volume: 29 Issue: 3

1. Research progression of CD133 as a marker of cancer stem cells. Page:243—247
2. The asymmetric division and tumorigenesis of stem cells. Page:248—253
3. Biologic characteristics of the side population of human small cell lung cancer cell line H446. Page:254—260
4. Research progress in cancer stem cells and their drug resistance. Page:261—264
5. Technology update for the sorting and identification of breast cancer stem cells. Page:265—269
6. Effects of heterochromatin in colorectal cancer stem cells on radiosensitivity. Page:270—276
7. Effects of ternary complexes of copper with salicylaldehyde-amino acid Schiff base coordination compounds on the proliferation of BGC823 cells. Page:277—282
8. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma. Page:283—287
9. Expression and clinical significance of syndecan-1 mRNA and HPA-1 mRNA in colorectal cancer detected with real-time fluorescent quantitative polymerase chain reaction. Page:288—293
10. Effect of celecoxib on proliferation, apoptosis, and survivin expression in human glioma cell line U251. Page:294—299
11. Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma. Page:300—305
12. Using 18F-FDG positron emission tomography/computed tomography to judge benign or malignant colorectal hypermetabolic lesions. Page:306—311
13. Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma. Page:312—316
14. Expression and clinical significance of Ezrin and E-cadherin in esophageal squamous cell carcinoma. Page:317—320
15. A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma. Page:321—324
16. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy. Page:325—329
17. Cancer incidence and mortality of children in urban districts of Guangzhou between 2000 and 2004. Page:330—332
18. Anticancer clinical utility of the apurinic/apyrimidinic endonuclease/redox factor-1 (APE/Ref-1). Page:333—339
19. Molecular-targeted therapy for cancer. Page:340—345
20. A case of primary liver carcinosarcoma: CT findings. Page:346—348